471,000 Mislabeled Insulin Syringes Recalled
A Massachusetts-based health care firm and the U.S. Food and Drug Administration issued a nationwide recall on Thursday for nearly half a million disposable hypodermic insulin syringes due to a mislabeling...To view the full article, register now.
Already a subscriber? Click here to view full article